Pharmaceutical and Biosciences

Understanding the EU Pharma Package and how to prepare for its implementation in 2028

Mar 19, 2026 | Tags: Patents , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Understanding the EU Pharma Incentives Review

Feb 26, 2026 | Tags: Patents , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

UK Supreme Court endorses EPO’s approach to computer-implemented inventions and discards Aerotel

Feb 12, 2026 | Tags: Patents , IP Insight , Aerospace , Automotive , Battery technology , Defence and Security , Engineering , Energy and environment , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences , Renewable energy , Sports , Software , Transportation

Medicine Authorisations and SPCs in the UK after the implementation of the Windsor Framework

Nov 11, 2024 | Tags: Patents , IP Insight , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

News Flash - Update to EPO’s practices concerning the filing of sequence listings for European divisional applications

Oct 5, 2023 | Tags: Patents , IP Insight , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Beyond Class 5 - Expanding trade mark protection for pharmaceutical and healthcare companies

May 15, 2023 | Tags: Trade Marks , Healthcare , Pharmaceutical and Biosciences

Compliant sequence listings for European divisionals post July 2022

Mar 10, 2023 | Tags: Patents , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Pharmaceutical, Healthcare and Cosmetic Products – beware what you claim in your advertising in the UK!

Oct 17, 2022 | Tags: Trade Marks , Food and drink , Healthcare , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Covid vaccine patent waivers – the opinion of our vaccine IP specialist

May 6, 2021 | Tags: Patents , IP Insight , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

“No Patents On Peppers”… or any plants or animals exclusively obtained by means of an essentially biological process

May 27, 2020 | Tags: Patents , IP Insight , Food and drink , Pharmaceutical and Biosciences

Mobile apps at the forefront of the Covid-19 fight

May 13, 2020 | Tags: Patents , Designs , Trade Marks , Healthcare , Pharmaceutical and Biosciences , Software

Institutions inject flexibility into IP relevant to COVID-19 vaccines and medicines

Apr 22, 2020 | Tags: Patents , Pharmaceutical and Biosciences

News Flash Update: EPO and EUIPO Deadlines extended

Mar 16, 2020 | Tags: Patents , Designs , Trade Marks , Pharmaceutical and Biosciences

Vitamins, Nutraceuticals and Trade Marks

Aug 12, 2019 | Tags: Trade Marks , Food and drink , Pharmaceutical and Biosciences

UK Supreme Court approves ‘Skinny Labelling’

Dec 18, 2018 | Tags: Patents , IP Insight , Pharmaceutical and Biosciences

The UK Supreme Court re-vitalises patent infringement by equivalents (pdf)

Jul 13, 2017 | Tags: Patents , Pharmaceutical and Biosciences